Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection.
about
Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection.Cellular immune responses against hepatitis C virus: the evidence base 2002Peptide vaccination in Montanide adjuvant induces and GM-CSF increases CXCR3 and cutaneous lymphocyte antigen expression by tumor antigen-specific CD8 T cells.Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activityPolyfunctional type-1, -2, and -17 CD8⁺ T cell responses to apoptotic self-antigens correlate with the chronic evolution of hepatitis C virus infection.Hepatitis B and hepatitis C co-infection in patients with HIV.HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells.Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.Regulation of hepatocyte fate by interferon-γ.A microRNA profile of human CD8(+) regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes.Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis CHepatitis C virus mutation affects proteasomal epitope processingBlocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.Evaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic HepatitisIntrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels.Host-virus interactions in hepatitis B and hepatitis C infection.Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection.Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming.Relationships between interleukin-12B and interleukin-10 gene polymorphisms and hepatitis C in Chinese Han hemodialysis patients.CD161(+)CD4(+) T cells are enriched in the liver during chronic hepatitis and associated with co-secretion of IL-22 and IFN-γPD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.Relationship between IL-10 gene -1082A/G and -592C/A polymorphisms and the risk of hepatitis C infection: a meta-analysis.Stronger hepatitis C virus-specific CD8+ T-cell responses in HIV coinfection.Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection.Innate immunity in hepatitis C virus infection: Interplay among dendritic cells, natural killer cells and natural killer T cells.Chemokine production during hypersensitivity pneumonitis.Major histocompatibility complex and T cell interactions of a universal T cell epitope from Plasmodium falciparum circumsporozoite protein.
P2860
Q27472916-74DD4251-F275-4C03-A2B5-CC820C27D253Q27480725-C3CABA1A-06CE-48C4-9956-C9E01635EEA5Q30409722-7F7D262E-4FEA-4740-93EB-E933BBF11A5CQ31112300-8B19B71B-7DEB-42A5-8BC2-35EB6F2CFDF0Q33812154-8A274D07-ED91-466E-88AB-2C386F27FEE8Q34318203-7BF24CF1-120D-4533-9721-BCD18AB7F098Q34323219-FF968B45-E0F5-43C6-B46C-30F8DE582B2CQ34510727-11C8F24F-BA48-40E5-BE32-E4105F1653F4Q34684239-0D5B2D19-CBD5-4836-8BFF-7B27D73B5601Q34748063-62F77407-C559-4CCC-84E2-9FF4BFC2220DQ35633815-D15A5B00-AC28-4A2C-B867-A73F14907E81Q35810531-937AF238-4E95-474A-9254-84CE7FB5D865Q35835376-8391C2C7-B9ED-429F-B618-48D437520789Q36369807-44A4D09E-30B0-4F00-9466-3EAE85FB8B33Q36418044-DA39A5E3-4371-44C1-9ECC-F89D2BA6A47CQ36491605-3453381A-085A-4197-9C24-87D891F497DDQ38740771-CE4B4C5A-0507-44A2-B05D-F11AD7CAE319Q39991596-360ACAC7-58EC-4ED7-8D46-D9CFF7F00039Q40725950-013BD0DD-E5D9-4596-8A98-EF999E9C943CQ40761226-2B0BD38D-4E02-49CB-88BE-64003966B2B6Q40795464-C98D4472-932A-495B-B642-C5711C221C6FQ41526399-A002CB77-F680-4C44-8D55-22BD3E21FD05Q41550051-4B5AB9E0-501A-4558-8374-792CAAF54419Q42017650-134BA3E3-22DD-47EA-B1F1-284FF668C556Q42279478-C8F9F70A-6D67-4F4F-AABD-B3273744074DQ42997258-9F5416D5-ABB2-46F2-898B-E28B56C7FBC4Q42997726-ED9B188C-7CDC-4D89-A503-82B49BB830BFQ44791785-7A14F170-E798-4017-AB9B-39610A709AF9Q45399738-9E90AD9A-1345-4B57-9782-7749B825548AQ48020890-FEC3B352-04F0-45D9-B1F0-7C27A19C11ABQ48026407-83D3FF14-DCBB-458B-9509-77580D3A2F45
P2860
Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Virus-specific CD8(+) T cells ...... c hepatitis C virus infection.
@ast
Virus-specific CD8(+) T cells ...... c hepatitis C virus infection.
@en
type
label
Virus-specific CD8(+) T cells ...... c hepatitis C virus infection.
@ast
Virus-specific CD8(+) T cells ...... c hepatitis C virus infection.
@en
prefLabel
Virus-specific CD8(+) T cells ...... c hepatitis C virus infection.
@ast
Virus-specific CD8(+) T cells ...... c hepatitis C virus infection.
@en
P2093
P2860
P1476
Virus-specific CD8(+) T cells ...... c hepatitis C virus infection.
@en
P2093
Abrignani S
Casciaro MA
Finocchi L
Francavilla V
Schiaffella E
P2860
P304
P356
10.1002/1521-4141(200103)31:3<894::AID-IMMU894>3.0.CO;2-I
P407
P577
2001-03-01T00:00:00Z